TTNP
🚫 does not pay dividends

Company News

Titan Pharmaceuticals Stock Surges 23% After Hours on Stockholder Approval of Three-Way Merger
Benzinga • Mohd Haider • August 27, 2025

Titan Pharmaceuticals' stockholders approved a business combination with Black Titan Corporation and TalenTec Sdn. Bhd., causing the stock to surge 23% in after-hours trading. The merger is still subject to additional closing conditions, including Nasdaq listing approval.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders
GlobeNewswire Inc. • Halper Sadeh Llc • July 26, 2025

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies undergoing mergers or sales transactions.

US Stocks Likely To Open Higher: Expert Says 'The Selling Pressure Is Starting To Be Exhausted'
Benzinga • Rishabh Mishra • April 14, 2025

U.S. stock futures rose on Monday as the selling pressure in the market appears to be exhausting. Investors assessed upbeat bank earnings and cooler-than-expected inflation data. The Commerce Secretary indicated that the electronics tariff exemptions are temporary, and further tariffs could follow soon.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, TTNP, FRZA on Behalf of Shareholders
GlobeNewswire Inc. • N/A • September 10, 2024

Halper Sadeh LLC is investigating potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders related to the proposed mergers/acquisitions of Iteris, Titan Pharmaceuticals, and Forza X1.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, K, TTNP on Behalf of Shareholders
GlobeNewswire Inc. • N/A • August 24, 2024

Halper Sadeh LLC, an investor rights law firm, is investigating the proposed sales of Bally's Corporation, Kellanova, and Titan Pharmaceuticals, Inc. to assess potential violations of federal securities laws and breaches of fiduciary duties to shareholders.

Related Companies